M13R (p.Met13Arg) variant of NFKBIA (NF-kappa-B inhibitor alpha)
M13R (p.Met13Arg) in NFKBIA (NF-kappa-B inhibitor alpha) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
M13R (p.Met13Arg) variant details
- p.Met13Arg
- NCI-TCGA Cosmic COSV9939
- cosmic curated COSV99395
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.29
- MetaSVM -0.79
- SIFT 0.30
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available